Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ASBPW held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Saba Capital Management, L.P. | 984K | $18K | 0.0% | 65.795% | 0.00% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1M | $17K | 0.0% | 70.236% | 0.00% |
| 3 | LINDEN ADVISORS LP | 900K | $17K | 0.0% | 60.202% | 0.00% |
| 4 | ARISTEIA CAPITAL LLC | 682K | $12K | 0.0% | 45.588% | 0.00% |
| 5 | Sculptor Capital LP | 500K | $9K | 0.0% | 33.446% | 0.00% |
| 6 | TORONTO DOMINION BANK | 516K | $9K | -0.0% | 34.539% | 0.00% |
| 7 | Clear Street Group Inc. | 331K | $5K | -0.0% | 22.119% | 0.00% |
| 8 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 273K | $4K | -48.0% | 18.261% | 0.00% |
| 9 | JPMORGAN CHASE & CO | 273K | $4K | +173.0% | 18.261% | 0.00% |
| 10 | D. E. Shaw & Co., Inc. | 200K | $3K | 0.0% | 13.378% | 0.00% |
| 11 | WOLVERINE ASSET MANAGEMENT LLC | 197K | $3K | 0.0% | 13.187% | 0.00% |
| 12 | Verition Fund Management LLC | 191K | $3K | -55.9% | 12.778% | 0.00% |
| 13 | Context Capital Management, LLC | 175K | $3K | 0.0% | 11.706% | 0.00% |
| 14 | Crossingbridge Advisors, LLC | 50K | $3K | 0.0% | 3.334% | 0.00% |
| 15 | Polar Asset Management Partners Inc. | 139K | $3K | 0.0% | 9.267% | 0.00% |
| 16 | LMR Partners LLP | 125K | $2K | 0.0% | 8.361% | 0.00% |
| 17 | PERISCOPE CAPITAL INC. | 125K | $2K | 0.0% | 8.356% | 0.00% |
| 18 | WHITEBOX ADVISORS LLC | 119K | $2K | 0.0% | 7.943% | 0.00% |
| 19 | VR Advisory Services Ltd | 100K | $2K | 0.0% | 6.669% | 0.00% |
| 20 | Limestone Investment Advisors LP | 75K | $1K | 0.0% | 5.017% | 0.00% |
| 21 | Blue Owl Capital Holdings LP | 50K | $1K | 0.0% | 3.345% | 0.00% |
| 22 | PICTON MAHONEY ASSET MANAGEMENT | 50K | $830 | 0.0% | 3.345% | 0.00% |
| 23 | OMERS ADMINISTRATION Corp | 25K | $415 | 0.0% | 1.672% | 0.00% |
| 24 | Beacon Pointe Advisors, LLC | 20K | $332 | 0.0% | 1.338% | 0.00% |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17K | $279 | — | 1.123% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ASBPW — a direct measure of their conviction.
Filings activity in ASBPW during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ASBPW position in Q1 2026
5 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 31 | +0.0% | 199.99% | +0.00 pp | $0M | 12% |
| Q4 2025 | 31 | 3.1% | 199.99% | +0.00 pp | $0M | 44% |
| Q3 2025 | 32 | +0.0% | 199.99% | +0.00 pp | $0M | 35% |
| Q2 2025 | 32 | +10% | 199.99% | +0.00 pp | $0M | 32% |
| Q1 2025 | 29 | — | 199.99% | — | $1M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ASBPW stock.
Based on Q1 2026 13F filings, institutional ownership of Aspire Biopharma Holdings, Inc. stands at 200.0%, held across 31 reporting institutions.
Saba Capital Management, L.P. is the largest reported institutional holder of ASBPW, with approximately 983,603 shares worth $0.00B as of Q1 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of ASBPW, including SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for ASBPW is 49 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
1 institutions opened new positions in ASBPW during Q1 2026, while 1 fully exited. 16 added to existing positions and 10 trimmed.
ASBPW institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 78.8% of all reported 13F value in ASBPW, and the top 25 account for 99.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Aspire Biopharma Holdings, Inc. (ASBPW) Institutional Ownership